AMH before IVF: what it predicts, what it does not, and why age still matters more
AMH is a good forecast of how many eggs stimulation may yield. It is a weak guide to egg quality or to whether a cycle will lead to a baby, and age still tells you more.
Anti-Müllerian hormone (AMH) is usually one of the first blood tests ordered before IVF, and it often becomes the number patients fixate on. That is understandable: it arrives as a single value, it is easy to compare online, and it sounds like a verdict on fertility. In practice, its job before IVF is much narrower. AMH helps a clinic forecast how your ovaries are likely to respond to stimulation medication. It says far less about whether a particular egg is healthy, or whether a particular cycle will end in a baby.
This guide explains what an AMH result can and cannot tell you before treatment, how clinics actually use it when planning a cycle, and the practical details (timing, units, contraception) that can make a result look better or worse than it really is.
What the AMH test is measuring
AMH is made by the small, early-stage follicles in the ovaries. Each of those follicles holds an immature egg. Broadly, the more of these small follicles you have, the higher your AMH tends to be. That is why AMH is used as a stand-in for "ovarian reserve": the pool of follicles that could potentially be recruited in a stimulated cycle.
The key word is stand-in. AMH is an indirect, population-level signal. It does not count eggs, and it does not look inside them. Two people with an identical AMH can retrieve quite different numbers of eggs, and the eggs they do retrieve can behave very differently in the lab.
What AMH is good at before IVF
According to the ASRM committee opinion (2020), AMH and AFC predict:
- Likely egg yield from ovarian stimulation.
- The risk of a poor response, meaning fewer eggs than hoped for.
- The risk of an excessive response, which matters because over-response raises the risk of ovarian hyperstimulation syndrome.
The same opinion notes that AMH and AFC perform roughly equally well, and that combining several ovarian-reserve markers has not consistently improved prediction. In plain terms, a clinic that has a reliable AMH and a good-quality AFC scan already has most of the forecasting value available. For how the scan side of the picture works, and why the two can disagree, see our guide to antral follicle count and IVF response.
What AMH is weak at
The same ASRM document is equally clear about the limits:
- Egg quality. AMH has only a weak association with oocyte quality. A low AMH does not mean your eggs are "bad"; a high AMH does not mean they are "good."
- Pregnancy and live birth after IVF. As an independent predictor, AMH is only weakly linked to these outcomes.
- Natural conception. In women without proven fertility, ovarian-reserve markers do not predict how quickly someone will conceive naturally. In women with infertility, ASRM concludes they are no more useful than age alone.
This is the most common misunderstanding we see. AMH is often treated as a countdown clock or a quality score. It is neither. It is a forecast of quantity under stimulation.
Why age still carries more weight
ASRM states that age is a much stronger predictor of reproductive success than ovarian reserve, and that ovarian reserve varies considerably between women of the same age. The reason is that age tracks something AMH cannot see: the likelihood that each egg is chromosomally normal.
| What you want to know | What AMH contributes | What age contributes |
|---|---|---|
| Roughly how many eggs stimulation may produce | A useful forecast, alongside AFC | Some information, but less specific |
| Which starting dose and protocol make sense | Often a major input | Considered alongside it |
| How likely each egg is to be chromosomally normal | Little | The main population-level signal |
| Chance of a live birth from treatment | Weak on its own | A much stronger predictor |
So a 33-year-old with a low AMH and a 42-year-old with a normal AMH are in very different positions, even though the first might retrieve fewer eggs. Those fewer eggs may each carry a better chance of developing into a healthy embryo. That is why a good consultation reads AMH and age together, not one in place of the other.
A very low AMH is not a reason to be turned away
Very low results are where AMH causes the most distress. ASRM's position is that an extremely low AMH can help counsel you about a likely suboptimal response, but it should not be used on its own to refuse treatment.
The committee cites an analysis of more than 5,000 cycles in women whose AMH was below 0.16 ng/mL. In that group, 54% of cycles were cancelled, and the live birth rate was 9.5% per cycle started (ASRM, 2020). That is a sobering figure, and it is a fair basis for a frank conversation about expectations, cost and alternatives. It is not zero. Where a clinic says IVF is "impossible" purely because of an AMH value, it is reasonable to ask how they reached that view. If you are in this situation, our guide to poor ovarian response covers what clinics may try once a low response is confirmed in a real cycle.
A high AMH is not automatically good news
A high AMH usually forecasts a strong response to stimulation, which sounds like an advantage. The flip side is that ASRM lists excessive response as one of the things AMH predicts. A clinic seeing a high value will usually think about gentler dosing, closer monitoring and a trigger strategy that lowers hyperstimulation risk. A high AMH can also be one sign among several that polycystic ovaries are part of the picture, which your doctor will want to assess with a scan and your cycle history.
Details that can change the number
Timing in the cycle
Unlike some hormone tests, AMH stays relatively consistent within and between menstrual cycles, so ASRM says it can be measured on any cycle day. You generally do not need to time the blood draw around your period.
Hormonal contraception
ASRM notes that AMH may read lower in people currently using hormonal contraception, so results taken on the pill, patch, ring or a hormonal IUD should be interpreted with caution. If your result looks out of step with your scan or your age, tell your clinic what you were taking when the blood was drawn.
Units and laboratories
Labs report AMH in different units, most often ng/mL in the United States and pmol/L in many other countries. A number that looks alarming in one unit may be unremarkable in the other. Different assay platforms can also give somewhat different values for the same sample. When you compare results, or send them to a new clinic, always include the unit, the lab name and the reference range printed on the report.
Your history
Previous ovarian surgery, chemotherapy or a known ovarian condition are all worth raising alongside the number, because they change how a clinician reads it.
How clinics actually use AMH when planning a cycle
In practice, AMH feeds into a handful of concrete decisions:
- Starting dose. Lower values often push toward a higher starting dose, and higher values toward a more cautious one. The aim is a reasonable number of eggs without over-response.
- Protocol choice. AMH is one input when choosing between protocols. Our protocol comparison covers the options.
- Counselling about yield. A clinic can give you a realistic range for egg numbers, which helps with planning, budgeting, and deciding whether more than one retrieval might be needed.
- Safety planning. High values prompt early thought about hyperstimulation prevention.
What AMH should not drive is a promise about outcome, in either direction.
Once you have had a cycle, the cycle matters more
AMH is a pre-treatment forecast. After a real stimulation, the clinic has something better: how your ovaries actually responded to a known dose, how many eggs were mature, how many fertilized and how embryos developed. If those observations and the AMH tell different stories, the observed response usually wins when planning the next attempt.
If you are planning treatment abroad
Many patients have AMH drawn locally before a virtual consultation with a clinic in another country. That works well if the report travels with its context. Send the original lab PDF rather than a typed-up number. Make sure it shows the unit, the reference range and the date, and add a note on any contraception you were using. A recent AFC scan report from the same period makes the picture far clearer. Our guide on sending medical records to a clinic abroad covers formats and translation.
Bring this to your consultation
- Your AMH report with unit, lab and reference range
- Whether you were using hormonal contraception at the time
- A recent antral follicle count, if you have one
- Any prior ovarian surgery or treatment
- Details of any previous stimulation: dose, egg numbers, maturity
- Your questions: what egg range do you expect, how does my age change that, and would this result change my dose or protocol?
AMH estimates how many eggs stimulation may find. Age, and what happens in the lab, say much more about what those eggs can become.
FAQ
Should I retest AMH if my first result was low?
A repeat test can make sense if the first was taken while you were using hormonal contraception, at a lab with unfamiliar units, or a long time ago. Repeating it simply hoping for a better number rarely changes the plan, because AMH and AFC together already carry most of the forecasting value.
Do I need to have my AMH drawn on a specific day of my cycle?
Generally no. ASRM notes AMH stays relatively stable within and between cycles, so it can usually be measured on any day. Follow your clinic's instructions if they bundle it with other tests that are day-specific.
Can supplements raise my AMH before IVF?
The ASRM guidance read for this article does not support using AMH as a target to raise with supplements. More importantly, a higher AMH reading would not by itself mean better-quality eggs. Ask your clinician before starting anything, especially during a treatment cycle.
My AMH is normal but I am 41. Why is my clinic cautious?
Because AMH forecasts egg quantity, while age is the stronger predictor of whether eggs are chromosomally normal and of live birth. A normal AMH at 41 may mean a reasonable egg yield, but it does not offset the effect of age on each egg.
Is a low AMH the same as early menopause?
No. A low AMH means the forecast pool of follicles responsive to stimulation is smaller than average for your age. It does not, by itself, tell you when menopause will happen or that you cannot conceive.
Planning treatment abroad?
If you are weighing treatment in another country, your AMH report is one of the first documents a clinic abroad will ask for. For destination, cost and travel planning, see IVFAbroad.co; for Colombia specifically, ColombianIVF.com and ColombiaMedical.co.
Ask about Colombia